PatternsRadar
Sign in

MEDPLUSMedplus Health Services Limited

NSE
603.95INR+11.00 (+1.86%)Close · 20 Nov 2026
27 Oct 2026Last results
Consumer ServicesSector
RetailingIndustry
₹7,257 CrMarket cap
34.4P/E (TTM)
64.6%Delivery

Filings & corporate actions

21 results filed
CSV
Next results · Q3 FY27
Expected 30 Jan 2027 – 15 Feb 2027
Estimate: filed 30–46 days after quarter end, last 5 times
2026
  • 27 OctresultsResults · Q2 FY27 · consolidated and standalone-1.9%NSE
  • 9 OctshareholdingShareholding · 30 Sept 2026-1.0%NSE
  • 21 JulresultsResults · Q1 FY27 · consolidated and standalone-12.8%NSE
  • 18 JulshareholdingShareholding · 30 Jun 20260.0%NSE
  • 20 MayresultsResults · Q4 FY26 · consolidated and standalone+4.7%NSE
  • 17 AprshareholdingShareholding · 31 Mar 2026+1.0%NSE
  • 30 JanresultsResults · Q3 FY26 · consolidated and standalone+2.9%NSE
  • 20 JanshareholdingShareholding · 31 Dec 2025-1.7%NSE

Reaction to results · all yearsrose on day 0 in 11 of 19 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY2727 Oct 2026-1.9%-3.4%—1.7×
Q1 FY2721 Jul 2026-12.8%-9.1%-18.2%18.7×
Q4 FY2620 May 2026+4.7%-1.7%-7.3%18.8×
Q3 FY2630 Jan 2026+2.9%+8.8%+6.1%1.2×
Q2 FY2631 Oct 2025+7.5%-0.4%+5.0%100.0×
Q1 FY262 Aug 2025+0.5%-9.2%-7.9%2.1×
Q4 FY2527 May 2025+1.7%-4.2%-6.9%4.9×
Q3 FY2531 Jan 2025+8.8%+10.1%+0.1%3.6×
Q2 FY2513 Nov 2024+1.2%+9.9%+26.6%9.8×
Q1 FY252 Aug 2024-1.0%-4.3%+3.8%2.7×
Q4 FY2429 May 2024-1.9%-0.8%-2.6%4.9×
Q3 FY242 Feb 2024-1.1%-9.2%+0.8%1.4×
Q1 FY247 Aug 2023-4.4%-5.0%-13.9%1.6×
Q4 FY2326 May 2023+17.9%+17.8%+13.5%79.5×
Q3 FY236 Feb 2023+2.4%+3.1%+10.2%0.5×
Q2 FY2311 Nov 2022+6.1%+9.5%+26.3%42.2×
Q1 FY2311 Aug 2022+0.9%+0.4%+0.2%0.9×
Q4 FY2230 May 2022-0.1%-4.3%-11.7%6.2×
Q3 FY2215 Feb 2022-1.3%-11.4%-6.9%0.6×
Average+1.6%-0.2%+1.0%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+21.3%
Profit YoY+1.0%
Interest cost YoY+23.1%
Revenue QoQ+8.4%
Profit QoQ+69.0%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+12.5%—+17.3%———
Profit+45.1%—+52.8%———

Key data

Open590.00
Day range583.00 – 607.00
52-week range565.60 – 1,022.20
From 52w high-40.9%
RSI (14)46.3
ATR (14)18.90
Volume2.36L
Avg volume (20D)1.74L
Rel volume1.36×
Volatility (1Y)29.7%
Turnover₹14.2Cr
Traded value (NSE)₹14.2Cr
VWAP599.79
SMA 50 / 200625.90 / 767.40
Price band20%

Delivery percentage

Latest · 20 Nov 202664.6%
20-day avg55.5%
1-year avg58.2%
Percentile (own history)80th
Range8.1–97.7%
Sessions1,215

Over the last 20 sessions MEDPLUS settled 55.5% of its traded quantity, which is above average for an NSE equity. Its one-year average is 58.2%, so recent sessions are running 2.7 points lower than usual. The latest session ranks higher than 80% of the 1,215 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders77.7K · +2.2% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy382 days ago
IndustryPharmacy Retail

Performance returns

1D1W1M3M6M1Y
Price+1.86%-2.46%+1.56%-7.98%-36.69%-22.69%

Valuation

Market cap₹7,257 Cr
Market cap (NSE)₹7,256 Cr
Free-float cap₹4,340 Cr
P/E (TTM)34.4
P/E (NSE)33.8
EPS (TTM)17.56
P/B3.5
Net margin (TTM)2.8%
Other income / PBT29.8%
ROE10.8%
Debt / equity0.00
Shares outstanding12.01Cr
Listed23 Dec 2021

Ownership

Promoter40.19%
Promoter Δ QoQ0.00 pp
Public59.76%
FII12.58%
DII31.89%
Pledged74.09%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)1,806.11,864.41,879.62,037.1
YoY chg+15.7%+23.5%+21.8%+21.3%
Net profit (₹ Cr)57.864.033.256.1
YoY chg+26.0%+24.7%-21.7%+1.0%
Net margin3.2%3.4%1.8%2.8%
EPS4.815.332.764.72

Shareholding over time

By quarter

30 Sept 2026 · promoter 40.19% · public 59.76%
22 Dec 2021: promoter 40.43%31 Dec 2021: promoter 40.43%31 Mar 2022: promoter 40.43%30 Jun 2022: promoter 40.43%30 Sept 2022: promoter 40.43%31 Dec 2022: promoter 40.43%31 Mar 2023: promoter 40.43%30 Jun 2023: promoter 40.43%30 Sept 2023: promoter 40.41%31 Dec 2023: promoter 39.00%31 Mar 2024: promoter 40.39%30 Jun 2024: promoter 40.39%30 Sept 2024: promoter 40.39%31 Dec 2024: promoter 40.39%31 Mar 2025: promoter 40.34%30 Jun 2025: promoter 40.32%30 Sept 2025: promoter 40.29%31 Dec 2025: promoter 40.29%31 Mar 2026: promoter 40.22%30 Jun 2026: promoter 40.19%30 Sept 2026: promoter 40.19%
2021-122026-09
  • Promoter
  • Public and others
Promoter
40.19%
Public
59.76%
Promoter change
0.00 pp
Filed
9 Oct 2026
FII
12.58%
DII
31.89%
Promoter pledged
74.09%

Who the public is

Mutual funds
27.39%

+2.88 pp QoQ

Insurance
1.19%

-1.24 pp QoQ

FPI
12.58%

-1.80 pp QoQ

Retail ≤ ₹2L
8.96%

-0.06 pp QoQ

HNI > ₹2L
1.84%

-0.04 pp QoQ

NRI
0.83%

-0.07 pp QoQ

Bodies corporate
3.11%

-0.09 pp QoQ

Shareholders
77,714

+2.2% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
LONE FURROW INVESTMENTS PRIVATE LIMITEDPromoter · Corporate14.38%
AGILEMED INVESTMENTS PRIVATE LIMITEDPromoter · Corporate13.03%
MADHUKAR REDDY GANGADIPromoter · Individual12.78%
ICICI PRUDENTIAL HEALTHCARE FUNDMutual fund7.46%
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA PHAMutual fund7.32%
FRANKLIN INDIA FLEXI CAP FUNDMutual fund3.90%
SBI ELSS TAX SAVER FUNDMutual fund3.39%
KOTAK SMALL CAP FUNDMutual fund3.31%
FIDELITY FUNDS - INDIA FOCUS FUNDFPI1.68%
PRAVESA HOLDING PRIVATE LIMITEDCorporate1.51%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
2.9 years ago
Disclosures on record
21
3 open-market of the newest 21
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
2 Jan 2024Lone Furrow Investments Private LimitedPromoterBuy9.1K₹67.5L739.851.72Cr → 1.72Cr14.45%+0.01 pp7(2)told 14 Dec 2023
2 Jan 2024Lone Furrow Investments Private LimitedPromoterBuy4.8K₹35.0L735.001.72Cr → 1.72Cr14.45%+0.00 pp7(2)told 14 Dec 2023
24 Dec 2021Madhavan GanesanOtherBuy5.0K₹55.0L1,100.00— → 5.0K0.00%7(3)told 23 Dec 2021

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Filings

CSV
Loading…

Bulk & block deals · 3 Nov 2025

CSV
12 of 37 deals
By year
DateDealClientQuantityPriceValue
3 Nov 2025Sell · bulkGRAVITON RESEARCH CAPITAL LLP6.73L837.39₹56.4Cr
3 Nov 2025Buy · bulkGRAVITON RESEARCH CAPITAL LLP6.74L836.74₹56.4Cr
18 Nov 2024Sell · block, also bulkPI OPPORTUNITIES FUND - I68.94L700.00₹482.6Cr
18 Nov 2024Buy · blockINVESCO MUTUAL FUND30.71L700.00₹215.0Cr
18 Nov 2024Buy · blockKOTAK MAHINDRA MUTUAL FUND30.71L700.00₹215.0Cr
18 Nov 2024Buy · blockFRANKLIN TEMPLETON MUTUAL FUND16.08L700.00₹112.6Cr
18 Nov 2024Sell · block, also bulkSBI MUTUAL FUND10.00L700.00₹70.0Cr
18 Nov 2024Buy · blockMORGAN STANLEY ASIA SINGAPORE PTE1.43L700.00₹10.0Cr
18 Nov 2024Buy · bulkKOTAK SMALL CAP FUND24.96L700.00₹174.7Cr
18 Nov 2024Buy · bulkINVESCO INDIA LARGE & MID CAP FUND11.32L700.00₹79.2Cr
18 Nov 2024Buy · bulkINVESCO TRUSTEE PVT LTD A/C INVESCO INDIA MIDCAP FUND9.84L700.00₹68.9Cr
18 Nov 2024Buy · bulkINVESCO TRUSTEE PVT LTD A/C INVESCO INDIA CONTRA FUND9.56L700.00₹66.9Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to MEDPLUS.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25AQ2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations1,441.51,490.51,488.81,576.21,561.41,509.61,542.61,679.31,806.11,864.41,879.62,037.1
Other income9.810.58.711.612.515.815.017.518.220.619.820.5
Total income1,451.31,501.01,497.51,587.81,574.01,525.41,557.71,696.81,824.41,885.01,899.42,057.7
Total expenses1,431.31,469.01,479.81,540.01,517.41,464.31,504.91,627.91,751.11,804.61,857.51,987.5
└ Finance costs24.525.124.725.126.026.827.428.830.833.533.336.6
└ Depreciation57.159.260.063.162.564.265.668.672.775.977.983.8
Profit before tax20.032.017.847.856.661.152.868.973.380.341.970.1
Tax expense6.3(1.6)3.49.110.79.810.413.415.516.48.714.1
Net profit13.733.614.338.745.951.342.355.557.864.033.256.1
EPS1.152.811.203.243.844.323.544.634.825.332.764.73
Net margin0.95%2.25%0.96%2.46%2.94%3.40%2.74%3.31%3.20%3.43%1.76%2.75%
PBT margin1.38%2.15%1.19%3.03%3.62%4.05%3.42%4.10%4.06%4.31%2.23%3.44%
Tax rate31.34%-4.93%19.36%19.01%18.96%16.03%19.75%19.49%21.15%20.37%20.80%20.07%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 27 Oct 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 H1 FY23FY23FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets2,626.12,796.73,004.83,155.13,360.13,572.23,932.54,197.8
Current assets1,502.21,480.71,567.61,712.41,843.51,965.02,068.72,178.9
└ Cash & equivalents40.2228.491.2124.086.1209.8198.4145.3
└ Other bank balances54.455.550.5143.6281.2292.1263.8135.5
└ Current investments0.00.00.00.00.00.00.081.8
└ Trade receivables7.18.717.518.013.318.127.038.5
└ Inventories1,017.81,144.11,340.21,340.71,345.11,280.71,381.71,521.1
Total equity1,440.01,490.51,577.41,635.71,739.91,844.31,974.72,067.6
└ Attributable to owners1,440.71,491.21,577.91,636.31,740.61,845.01,975.42,068.3
└ Non-controlling interest(0.6)(0.7)(0.6)(0.6)(0.7)(0.7)(0.7)(0.7)
└ Share capital23.923.923.923.923.924.024.024.0
Borrowings0.00.00.00.00.00.00.00.0
└ Current0.00.00.00.00.00.00.00.0
└ Non-current0.00.00.00.00.00.00.00.0
Trade payables283.6260.1253.0305.6299.0339.3307.0364.2
Current liabilities471.8476.6525.9563.4576.6676.9689.3768.8
Total liabilities1,186.01,306.21,427.41,519.41,620.21,727.91,957.92,130.3
Net debt(94.6)(283.9)(141.7)(267.6)(367.2)(501.9)(462.2)(362.6)
Debt / equity0.000.000.000.000.000.000.000.00
Current ratio3.183.112.983.043.202.903.002.83

Cash flow, year to date

 H1 FY23FY23FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow43.890.4143.7272.6540.4313.3495.6162.2
└ Capex(95.7)(169.0)(84.4)(29.1)(59.5)(42.8)(123.0)(77.5)
Free cash flow(51.9)(78.6)59.3243.6481.0270.6372.684.7
Investing cash flow199.6429.4(82.8)(129.5)(317.6)(68.1)(127.7)(65.6)
Financing cash flow(82.0)(170.2)(198.1)(110.4)(228.0)(121.6)(255.5)(149.6)
└ Dividends paid0.00.00.00.00.00.00.00.0
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash161.4349.6(137.2)32.8(5.2)123.7112.4(53.1)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

MEDPLUS at a glance

  • MEDPLUS closed at ₹603.95 on 20 Nov 2026, +1.86% on the day, -22.7% over one year, 40.9% below its 52-week high of ₹1,022.2.
  • Delivery was 64.6% of traded quantity on 20 Nov 2026, the 80th percentile of its own 1,215 sessions with a reading (20-session average 55.5%, 1-year average 58.2%).
  • Market capitalisation is ₹7,257 crore at a trailing P/E of 34.4 (trailing EPS ₹17.56).
  • Q2 FY27 results (consolidated, filed 27 Oct 2026): revenue ₹2,037 crore (+21.3% year on year), net profit ₹56 crore (+1.0%); the price moved -1.9% on the first session after.
  • Promoters held 40.19% at 30 Sept 2026, unchanged on the previous filing, with 74.09% of promoter shares pledged.
  • Q3 FY27 results are expected between 30 Jan 2027 and 15 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorConsumer Discretionary
Basic industryPharmacy Retail
ISININE804L01022
SeriesEQ
Listed23 Dec 2021
IPO price796.00 · band Rs. 780 to Rs.796
IPO listing23 Dec 2021
NSE market cap · 17 Nov 2026₹7,316 Cr
Free-float market cap (NSE)₹4,373 Cr
Shares outstanding (NSE)12.02Cr
History from23 Dec 2021
Sessions1,218
Turnover rank#956

Sector history

  1. to 16 Aug 2026Index industry · Consumer Services
  2. from 16 Aug 2026Consumer Discretionary › Consumer Services › Retailing › Pharmacy Retail

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.